Kyverna is leading other companies in the CAR-T sector. Their flagship product is KYV-101. It takes cells from the patient and engineers them with CD28 stimulation. Kyverna’s KYSA-8 delivered data on ...

Bob Herman covers health insurance, government programs, hospitals, physicians, and other providers — reporting on how money influences those businesses and shapes what we all pay for care. He is also ...

Make better investment decisions with Simply Wall St's easy, visual tools that give you a competitive edge. Alvotech (NasdaqGM:ALVO) reported positive clinical trial results for AVT80, its biosimilar ...

The study, which assessed the pharmacokinetics, safety, tolerability and immunogenicity of AVT80 compared to Entyvio® in healthy adult participants, met all its primary endpoints The PK study ...

REYKJAVIK, Iceland, Feb. 05, 2026 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients ...

The study, which assessed the pharmacokinetics, safety, tolerability and immunogenicity of AVT80 compared to Entyvio® in healthy adult participants, met all its primary endpoints REYKJAVIK, Iceland, ...

New guidelines for treating Crohn's disease emphasize early use of higher-efficacy advanced therapies over step-up approaches. The strongest support went to seven advanced therapies that are all ...

Humira (adalimumab) is a biologic medication used to treat several chronic inflammatory conditions, including rheumatoid arthritis, Crohn’s disease, and plaque psoriasis. For years, it has been one of ...

Add Yahoo as a preferred source to see more of our stories on Google. FILE PHOTO: A sign stands outside a Abbvie facility in Cambridge, Massachusetts, U.S., May 20, 2021. REUTERS/Brian Snyder/File ...